- Home
- SST vs VNRX Comparison
SST vs VNRX Comparison
Compare SST & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- VNRX
- Stock Information
- Founded
- SST 2013
- VNRX N/A
- Country
- SST United States
- VNRX United States
- Employees
- SST N/A
- VNRX N/A
- Industry
- SST Diversified Commercial Services
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SST Consumer Discretionary
- VNRX Health Care
- Exchange
- SST Nasdaq
- VNRX Nasdaq
- Market Cap
- SST 57.3M
- VNRX 64.8M
- IPO Year
- SST N/A
- VNRX N/A
- Fundamental
- Price
- SST $7.57
- VNRX $0.62
- Analyst Decision
- SST Strong Buy
- VNRX Strong Buy
- Analyst Count
- SST 1
- VNRX 4
- Target Price
- SST $10.00
- VNRX $3.50
- AVG Volume (30 Days)
- SST 51.7K
- VNRX 196.8K
- Earning Date
- SST 11-06-2025
- VNRX 08-14-2025
- Dividend Yield
- SST N/A
- VNRX N/A
- EPS Growth
- SST N/A
- VNRX N/A
- EPS
- SST N/A
- VNRX N/A
- Revenue
- SST $317,055,000.00
- VNRX $1,319,252.00
- Revenue This Year
- SST N/A
- VNRX $274.46
- Revenue Next Year
- SST $12.20
- VNRX $212.60
- P/E Ratio
- SST N/A
- VNRX N/A
- Revenue Growth
- SST N/A
- VNRX 35.10
- 52 Week Low
- SST $2.90
- VNRX $0.40
- 52 Week High
- SST $15.00
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- SST 58.58
- VNRX 41.25
- Support Level
- SST $6.62
- VNRX $0.57
- Resistance Level
- SST $7.90
- VNRX $0.73
- Average True Range (ATR)
- SST 0.83
- VNRX 0.04
- MACD
- SST 0.06
- VNRX -0.01
- Stochastic Oscillator
- SST 71.10
- VNRX 25.63
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.